Back to search

Article

Development of a neutralization monoclonal antibody with a broad neutralizing effect against SARS-CoV-2 variants

2023-08-21

Abstract excerpt

<h4>Background: </h4> The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants has challenged the effectiveness of current therapeutic regimens. Here, we aimed to develop a potent and broad SARS-CoV-2 antibody therapeutic by screening a scFv library with the spike protein receptor-binding domain (RBD) via phage display. Methods SKAI-DS84 was identified through phage display, and it u...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
57eba833-79d2-5bee-84e4-7a0e1678a76b
DOI
10.21203/rs.3.rs-3261636/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Development of a neutralization monoclonal antibody with a broad neutralizing effect against SARS-CoV-2 variantsDOI 10.21203/rs.3.rs-3261636/v1
Select a neighboring publication to make it the new centre.